Form 4: Pulmonx Corp Executive Lehman Sells Shares to Cover Tax Obligations, Receives Stock Grant
SEC Form 4 Filing
David Aaron Lehman, General Counsel of Pulmonx Corp, sold shares to cover tax obligations related to vesting Restricted Stock Units and received a grant of additional RSUs.
Summary
- David Aaron Lehman, General Counsel of Pulmonx Corp, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Lehman sold a total of 22,355 shares of common stock at a price of $7.14 and $7.97 per share.
- These sales were to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) granted on June 1, 2021, March 1, 2022, March 1, 2023 and March 1, 2024.
- The sales were executed pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2024.
- Lehman also received a grant of 108,000 RSUs on March 3, 2025, which vest in equal quarterly installments over four years.
- Following these transactions, Lehman beneficially owns 283,496 shares of Pulmonx Corp common stock.
Sentiment
Score: 6
Explanation: The document reflects routine insider transactions. The stock sales are for tax obligations, and the RSU grant is a standard compensation practice. Overall, the sentiment is neutral.
Positives
- Lehman received a grant of 108,000 RSUs, indicating continued alignment with the company's long-term success.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are a routine part of insider trading activity and provide transparency into the transactions of company executives. The sale of shares to cover tax obligations is a common practice.
Comparison to Industry Standards
- Comparing Lehman's transactions to those of executives at similar medical device companies would provide a better understanding of whether these actions are typical.
- Analyzing the vesting schedules and RSU grants relative to industry benchmarks could offer insights into Pulmonx's compensation practices.
- Reviewing the adoption of 10b5-1 trading plans among peer companies would help contextualize Lehman's trading activity.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price.
- The RSU grant aligns executive interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| June 1, 2021 | Date of RSU grant related to tax obligations covered by stock sales. |
| March 1, 2022 | Date of RSU grant related to tax obligations covered by stock sales. |
| March 1, 2023 | Date of RSU grant related to tax obligations covered by stock sales. |
| March 1, 2024 | Date of RSU grant related to tax obligations covered by stock sales. |
| November 18, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| February 24, 2025 | Date of Power of Attorney execution. |
| March 3, 2025 | Date of stock sales and RSU grant. |
| March 5, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.